Table 2.
Quantification of Immunohistochemical Analysis in LPS Xenografts
Marker and xenograft | Staining score (density/intensity)∗ |
|||
---|---|---|---|---|
Vehicle | Rapamycin | Sorafenib | Combination | |
p-S6 | ||||
LPSX1 | 2/3+ | 1/1+ | 2/2+ | 1/1+ |
LPSX2 | 2/3+ | 1/1+ | 2/2+ | 1/1+ |
LPSX3 | 2/3+ | 1/1+ | 2/2+ | 1/1+ |
p-ERK | ||||
LPSX1 | 2/2+ | 3/2+ | 3/2+ | 3/2+ |
LPSX2 | 1/1+ | 1/1+ | 2/3+ | 2/1+ |
LPSX3 | 2/1+ | 2/1+ | 2/2+ | 2/1+ |
Staining density is scored as <1, negative staining; 1, 1% to 25% of tumor cells staining; 2, 26% to 74% of tumor cells staining; 3, ≥75% of tumor cells staining. Staining intensity is scored as 1+, weak; 2+, moderate; 3+, strong.